TP53 and colonic neoplasm: In conclusion, our study demonstrates for the first time that dysregulated phosphorylation of the N-terminus and C-terminus serine residues of mutant p53 protein critically contributes to impaired sensitivity of mutant p53-harboring HT 29 colon cancer cells to OX (Figure 7).